🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

225 results for “Shanghai” Clear

  1. Clifutinib Besylate

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Acute Myeloid Leukemia

    phase 1 small molecule completed

    1 trial

  2. Clifutinib with fed state

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Acute Myeloid Leukemia in Children

    phase 1 small molecule completed

    1 trial

  3. Donepezil Dihydroxynaphthalate for Injection

    Shanghai University of Traditional Chinese Medicine

    Alzheimer Disease

    phase 1 small molecule active

    1 trial

  4. Drug 601

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Wet Age-related Macular Degeneration

    phase 1 small molecule active

    1 trial

  5. Drug 601

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Diabetic Macular Edema

    phase 1 small molecule active

    1 trial

  6. Freethiadine tablets(part I)

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Hepatitis B, Chronic

    phase 1 small molecule completed

    1 trial

  7. GC1102

    Green Valley (Shanghai) Pharmaceuticals Co.,

    Hepatitis B

    phase 1 mab completed

    1 trial

  8. HB0056

    Shanghai University of Traditional Chinese Medicine

    Healthy

    phase 1 small molecule active

    1 trial

  9. HBT-708

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Advanced Solid Tumors

    phase 1 small molecule active

    1 trial

  10. HEC 68498

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Idiopathic Pulmonary Fibrosis

    phase 1 small molecule completed

    1 trial

  11. HEC-007 injection

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Healthy Subjects

    phase 1 small molecule active

    1 trial

  12. HEC-151 Injection

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Healthy Adult Male

    phase 1 small molecule active

    1 trial

  13. HEC113995

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Major Depressive Disorder

    phase 1 small molecule completed

    1 trial

  14. HEC113995 PA•H2O tablets

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Major Depressive Disorder

    phase 1 small molecule completed

    1 trial

  15. HEC113995PA•H2O tablet

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Healthy

    phase 1 small molecule completed

    1 trial

  16. HEC116094

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Influenza

    phase 1 small molecule completed

    1 trial

  17. HEC122505MsOH

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Parkinson Disease

    phase 1 small molecule completed

    1 trial

  18. HEC169584 capsule

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Non - Alcoholic Steatohepatitis

    phase 1 small molecule active

    1 trial

  19. HEC30654AcOH capsule

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Healthy

    phase 1 small molecule completed

    1 trial

  20. HEC53856

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Chronic Kidney Diseases

    phase 1 small molecule completed

    1 trial

  21. HEC53856

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Healthy

    phase 1 small molecule completed

    1 trial

  22. HEC53856

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Hemodialysis

    phase 1 small molecule completed

    1 trial

  23. HEC68498

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Advanced Refractory Solid Tumors

    phase 1 small molecule completed

    1 trial

  24. HEC73077 tablets

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Diabetic Nephropathy

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources